Preview

The Clinician

Advanced search

ERYTHEMA NODOSUM IN LÖFGREN’S SYNDROME

https://doi.org/10.17650/1818-8338-2016-10-1-22-28

Abstract

Objective: to study the clinical, laboratory, and radiographic characteristics of early-stage sarcoidosis in a cohort of patients referred to a rheumatology center.
Materials and methods. The investigation enrolled 125 patients (104 women and 21 men; mean age 42 ± 12 years) with the clinical and X-ray signs of Löfgren’s syndrome. All the patients were referred to a rheumatology center with diagnosed erythema nodosum (EN). The median disease duration was 1 (0.5–2.0) month. All the patients underwent comprehensive clinical examination and laboratory and instrumental studies of biochemical and immunological parameters, chest X-ray or computed tomography (CT), as well as postmortem examinations of skin and subcutaneous fat biopsy specimens were done in 15 cases.
Results. EN was located on the lower leg mostly on its anterior surface (97 %), hip (35 %), upper limbs (25 %), and trunk (3 %). There was a symmetric pattern of eruptions in 50 % of the patients. Nodules fused into a conglomerate in 48 %. More than 50 % injury of the shin surface (68 %) was directly related to the number of nodules (p < 0.001; r = 0.60) and the level of C-reactive protein (p = 0.006; r = 0.38). There was a direct relationship of the number of nodules to the duration of EN (p = 0.04; r = 0.20) and their trend of fusion (p < 0.001; r = 0.39). The signs of joint injury were found in 106 (85 %) patients. The predictors of the CT frosted glass phenomenon were male sex (odds ratio (OR) 6.5; confidence interval (CI) 1.2–35.0; p = 0.026) and the presence of nodular conglomerates (OR 4.8; CI 1.4–16.1; p = 0.01). EN did not recur and articular syndrome virtually completely regressed in 90% of the patients during one-year follow-up.
Conclusion. Patients with acute sarcoidosis require that physicians of different specialties, including rheumatologists, should coordinate their actions to determine the volume of further examination and to use adequate treatment. 

About the Authors

Yu. A. Karpova
V.A. Nasonova Research Institute of Rheumatology; 34A Kashrskoe Shosse, Moscow, 115522, Russia
Russian Federation


B. S. Belov
V.A. Nasonova Research Institute of Rheumatology; 34A Kashrskoe Shosse, Moscow, 115522, Russia
Russian Federation


O. N. Egorova
V.A. Nasonova Research Institute of Rheumatology; 34A Kashrskoe Shosse, Moscow, 115522, Russia
Russian Federation


N. M. Savushkina
V.A. Nasonova Research Institute of Rheumatology; 34A Kashrskoe Shosse, Moscow, 115522, Russia
Russian Federation


S. I. Glukhova
V.A. Nasonova Research Institute of Rheumatology; 34A Kashrskoe Shosse, Moscow, 115522, Russia
Russian Federation


S. G. Radenska-Lopovok
V.A. Nasonova Research Institute of Rheumatology; 34A Kashrskoe Shosse, Moscow, 115522, Russia
Russian Federation


References

1. Чучалин А.Г., Авдеев С.Н., Баранова О.Л. и др. Диагностика и лечение саркоидоза (Федеральные согласительные клинические рекомендации). 2014. Доступно по ссылке: www.pulmonology.ru/publications/ guide.php. [Chuchalin A.G., Avdeev S.N., Baranova O.L. et al. Diagnosis and treatment of sarcoidosis (Federal consensus clinical guidelines). 2014. Available at: www.pulmonology.ru/publications/guide.php. (In Russ.)].

2. Kobak S. Sarcoidosis: a rheumatologist’s perspective. Ther Adv Musculoskelet Dis 2015;7(5):196–205.

3. Dönmez S., Kisacik B., Pamuk O.N. et al. Are clinical features in Löfgren’s syndromerelated erythema nodosum different from idiopathic erythema nodosum? Sarcoidosis Vasc Diffuse Lung Dis 2012;29(2):128–31.

4. Визель Н.Ю., Визель А.А. Характеристика больных саркоидозом в Республике Татарстан. Вестник современной клинической медицины 2015;8(5):18–26. [Vizel’ N.Yu., Vizel’ А.А. Profile of patients with sarcoidosis in the Republic of Tatarstan. Vestnik sovremennoy klinicheskoy meditsiny = Journal of Modern Clinical Medicine 2015;8(5):18–26. (In Russ.)].

5. Mana J., Gomez-Vaquero C., Montero A. et al. Löfgren’s syndrome revisited: a study of 186 patients. Am J Med 1999;107(3):240–5.

6. Лебедева М.В., Попова Е.Н., Шовская Т.Н. Саркоидный артрит: проблемы диагностики и лечения. Фарматека 2011;(18):45–7. [Lebedeva M.V., Popova E.N., Shovskaya Т.N. Sarcoid arthritis: problems of diagnosis and treatment. Farmateka = Pharmateca 2011;(18):45–7. (In Russ.)].

7. Glennås A., Kvien T.K., Melby K. et al. Acute sarcoid arthritis: occurrence, seasonal onset, clinical features and outcome. Br J Rheumatol 1995;34(1):45–50.

8. Ungprasert P., Carmona E.M., Utz J.P. et al. Epidemiology of Sarcoidosis 1946–2013: A Population-Based Study. Mayo Clin Proc 2016;91(2):183–8.

9. Tejera Segura B., Holgado S., Mateo L. et al. Löfgren syndrome: a study of 80 cases. Med Clin (Barc) 2014;143(4):166–9.

10. Pettersson T. Sarcoid and erythema nodosum arthropathies. Baillieres Best Pract Res Clin Rheumatol 2000;14(3):461–76.

11. Judson M.A. Advances in the diagnosis and treatment of sarcoidosis. F1000Prime Rep 2014;6:89.

12. Govender P., Berman J.S. The Diagnosis of Sarcoidosis. Clin Chest Med 2015;36(4):585–602.


Review

For citations:


Karpova Yu.A., Belov B.S., Egorova O.N., Savushkina N.M., Glukhova S.I., Radenska-Lopovok S.G. ERYTHEMA NODOSUM IN LÖFGREN’S SYNDROME. The Clinician. 2016;10(1):22-28. (In Russ.) https://doi.org/10.17650/1818-8338-2016-10-1-22-28

Views: 3888


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1818-8338 (Print)
ISSN 2412-8775 (Online)